logo
Zepto's food facility in Dharavi shut down by FDA over poor hygiene, safety violations

Zepto's food facility in Dharavi shut down by FDA over poor hygiene, safety violations

Hans India01-06-2025
Maharashtra's Food and Drug Administration (FDA) has cancelled the food business licence of Zepto's facility in Dharavi after a surprise inspection found multiple serious violations of food safety rules.
This move is part of a larger crackdown on Zepto's operations in Mumbai. According to FDA officials, the inspection at the Dharavi location revealed poor hygiene and unsafe food storage conditions.
Some food items were found with fungal growth, while others were stored near stagnant water. The cold storage units were not keeping the required temperature, and the floors were dirty and wet.
Inspectors also found expired food items not clearly separated from the fresh stock. The inspection was triggered by a tip-off received from the Minister of State for FDA, Yogesh Kadam.
Based on the findings, the Assistant Commissioner, Food, Anupamaa Balasaheb Patil, ordered the suspension of the facility's licence under Section 32(3) of the Food Safety and Standards Act, 2006.
This suspension will remain in place until Zepto corrects all the issues and gets clearance from the licensing authority.
Zepto, a fast-growing quick commerce company, has also faced inspections at its Bhiwandi, Bandra East, and Borivali facilities.
While the licences at Bhiwandi and Bandra East were not cancelled, notices were issued for violations.
In Borivali, the licence was temporarily suspended, but operations resumed after corrective measures were taken and approved by the appellate authority.
A Zepto spokesperson said: "Maintaining the highest standards of food safety and hygiene is non-negotiable. We have already started an internal review and are working with authorities to fix the issues quickly."
This is not the first controversy for Zepto. The company has recently faced criticism from customers for allegedly increasing delivery charges and using deceptive practices on its app.
Social media has seen a rise in complaints from users expressing disappointment with the company.
Zepto CEO Aadit Palicha has also made headlines recently, accusing the CFO of a rival company of spreading false information and funding bots to damage Zepto's reputation.
In another blow, Zepto's Rural Mobilisation Programme is under scrutiny. The Rajdhani App Workers Union has accused the company's recruitment partners of unfairly reducing the wages of delivery agents from small towns and keeping them in poor living conditions.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Skittles, M&Ms To Be Naturally Dyed Soon, Says Candy-Maker Company
Skittles, M&Ms To Be Naturally Dyed Soon, Says Candy-Maker Company

NDTV

time3 hours ago

  • NDTV

Skittles, M&Ms To Be Naturally Dyed Soon, Says Candy-Maker Company

Two days after Mars Inc. met with Food and Drug Administration Commissioner Marty Makary, the privately held food company posted a statement saying it would offer naturally colored options next year for four of its most iconic candies, including M&M's and Skittles. The July 24 announcement on the Mars Wrigley website went largely unnoticed at a time when candymakers have been viewed as the biggest holdout in the Trump administration's efforts to get companies to voluntarily strip synthetic dyes from their food. The move by Mars marks a step toward appeasing Health and Human Services Secretary Robert F. Kennedy Jr., who has made artificial dyes a top target. Consumers have pressed for more natural options, and some states have passed new restrictions, including West Virginia, which will prohibit the sale of food with synthetic dyes starting in 2028. Mars, however, stopped short of removing artificial dyes from all of its brands, saying it continues to work on that effort. "When we have identified fully effective, scalable solutions across the entire portfolio, we will share additional item commitments and timelines," the company said in the statement. An FDA spokesperson applauded Mars for its action on synthetic dyes and called the move "a win for parents, consumers and public health." Other food companies have made broader statements pledging to remove synthetic dyes from vast swaths of their products. Hershey Co., which makes Hershey's chocolates and Jolly Rancher candy, for example, said in late June that it would remove artificial dyes from its portfolio by the end of 2027. Representatives of Mars met with Makary on July 22, according to his public calendar. "I think we're going to get there with Mars," Makary said the next day on a Politico podcast.

Amansa Investments pumps Rs 250 cr in Rubicon Research in pre-IPO funding round
Amansa Investments pumps Rs 250 cr in Rubicon Research in pre-IPO funding round

News18

time6 hours ago

  • News18

Amansa Investments pumps Rs 250 cr in Rubicon Research in pre-IPO funding round

New Delhi, Aug 14 (PTI) Amansa Investments Ltd has invested Rs 250 crore in pharma formulation firm Rubicon Research Ltd through a pre-initial public offering (IPO) funding round. As part of the transaction, General Atlantic Singapore RR Pte Ltd, one of Rubicon Research's promoters, transferred 51.60 lakh equity shares to Amansa Investments at Rs 484.47 per share, amounting to Rs 250 crore, the company said in a public announcement. At the time of filing draft papers in July 2024, General Atlantic held 8.89 crore equity shares, representing a 57.57 per cent stake. Following the pre-IPO deal, it will hold 8.37 crore equity shares, or 54.01 per cent of the company. The transaction, conducted in consultation with the book running lead managers (BRLMs) of Rubicon Research, received board approval on August 12. Other promoters of the company include Pratibha Pilgaonkar, Sudhir D Pilgaonkar, Parag S Sancheti, Surabhi P Sancheti, and Sumant S Pilgaonkar. Rubicon Research's proposed IPO consisted of a fresh issue of equity shares worth Rs 500 crore alongside an offer-for-sale of shares valued Rs 585 crore. Following the latest fundraise, the size of the fresh issue has been reduced by Rs 250 crore. The company plans to utilise proceeds from the fresh issue for payment of debt, supporting inorganic growth through unidentified acquisitions as well as other strategic initiatives and general corporate purposes. The pharma firm has two US FDA-inspected research and development (R&D) facilities, one each in India and Canada, and two manufacturing facilities in India with multiple accreditations from multiple regulatory agencies such as USFDA, Food and Drugs Administration, Maharashtra (WHO-GMP accreditation) and Health Canada. As on March 31, 2024, Rubicon Research had a portfolio of 69 products approved by the USFDA, 19 new drugs awaiting USFDA's nod and 46 products in various stages of development. PTI SP DRR view comments First Published: August 14, 2025, 12:15 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

Influencer arrested in Rs 40 crore money laundering case linked to Reliance Capital
Influencer arrested in Rs 40 crore money laundering case linked to Reliance Capital

India Today

time15 hours ago

  • India Today

Influencer arrested in Rs 40 crore money laundering case linked to Reliance Capital

The Enforcement Directorate has arrested an Instagram influencer for being involved in a high-profile money laundering scam. Sandeepa Virk, who boasts overs 1.2 million followers was arrested for allegedly having links to Angarai Natarajan Sethuraman, former Director of the now-defunct Reliance Capital probe stems from an FIR by Punjab Police under cheating and criminal breach of trust charges. ED alleges that Virk, through misrepresentation and false promises, acquired properties and laundered illicit funds, using her website — under the veil of selling FDA-approved beauty to investigators, the site's products were non-existent, the payment system non-functional, and social media engagement minimal, pointing to a sham operation. Searches at Sethuraman's residence revealed illegal communications with Virk and alleged fund found that in 2018, Rs 18 crore of public money from Reliance Commercial Finance Ltd (RCFL) was disbursed to Sethuraman in violation of lending norms, with principal and interest payments deferred, waivers granted, and no due from this, Reliance Capital sanctioned him a Rs 22-crore home loan, also in violation of prudential norms. Large portions of these loans remain unpaid and are suspected to have been siphoned incriminating documents have been seized, and statements of key associates, including Farrukh Ali, have been recorded. Virk was produced in court on August 12 and remanded to ED custody until August 14 for further agency is now probing whether Virk's lavish lifestyle, prominently showcased to her massive social media following, was funded through diverted Reliance-linked funds and other fraudulent a statement to India Today, Sethuraman refuted all the allegations. "These allegations are entirely baseless," he said while firmly denying any connection or involvement with Virk or any transactions related to claimed that the home loan he received from Reliance Capital was granted following due process and was secured by the property offered as collateral.- Ends

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store